Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022

Author's Avatar
Jan 09, 2023

WOBURN, MA / ACCESSWIRE / January 9, 2023 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced preliminary, unaudited revenues for the three and 12 months ended December 31, 2022.